发明名称 MARKERS ASSOCIATED WITH THE THERAPEUTIC EFFICACY OF GLATIRAMER ACETATE
摘要 The present invention is directed to methods and kits based, at least in part, on the identification of allele-specific responsiveness or non-responsiveness to glatiramer acetate for the treatment of immune disorders, such as relapsing-remitting multiple sclerosis. The allele-specific responsiveness or non-responsiveness is based on polymorphisms in the following genes, CTSS, MBP, TCRB, CD95, CD86, IL-1R1, CD80, SCYA5, MMP9, MOG, SPP1 and IL-12RB2.
申请公布号 EP1891233(A4) 申请公布日期 2010.03.24
申请号 EP20060758673 申请日期 2006.04.24
申请人 YEDA RESEARCH AND DEVELOPMENT CO., LTD.;TEVA PHARMACEUTICAL INDUSTRIES, LTD.;RAPPAPORT FACULTY OF MEDICINE AND RESEARCH INSTITUTE 发明人 LANCET, DORON;BECKMANN, JACQUES;AVIDAN, NILI;BEN-ASHER, EDNA;GOLDSTAUB, DAN;HAYARDENY, LIAT;GROSSMAN, IRIS;MILLER, ARIEL;SINGER, CLARA
分类号 C12Q1/68 主分类号 C12Q1/68
代理机构 代理人
主权项
地址